![](/img/cover-not-exists.png)
Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia
Malkan, Umit Y., Haznedaroglu, Ibrahim C.Volume:
14
Language:
english
Journal:
Open Medicine
DOI:
10.1515/med-2019-0004
File:
PDF, 663 KB
english